Butazolidin side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Butazolidin. Common side effects include drug hypersensitivity among females and pulmonary fibrosis among males.

The phase IV clinical study is created by eHealthMe based on 67 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 18, 2023

67 people who take Butazolidin and have side effects are studied.


What is Butazolidin?

Butazolidin has active ingredients of phenylbutazone. eHealthMe is studying from 67 Butazolidin users for its effectiveness, alternative drugs and more.

Number of Butazolidin reports submitted per year:

Butazolidin side effects.

Butazolidin side effects by time on the drug*:

< 1 month:

  1. Haemoglobin decreased
  2. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands)
  3. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  4. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  5. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  6. Erysipelas (bacterial skin infection)

1 - 6 months:

  1. Cheilitis (infection of lips)

6 - 12 months:

n/a

1 - 2 years:

  1. Ankylosing spondylitis (type of arthritis affecting the spine)

2 - 5 years:

n/a

5 - 10 years:

  1. Agitation (state of anxiety or nervous excitement)
  2. Anaemia (lack of blood)
  3. Crohn's disease (condition that causes inflammation of the gastrointestinal tract)

10+ years:

n/a

not specified:

  1. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  2. Drug hypersensitivity
  3. Lung neoplasm malignant (cancer tumour of lung)
  4. Deafness bilateral
  5. Abdominal pain
  6. Ankylosing spondylitis (type of arthritis affecting the spine)
  7. Drug ineffective
  8. Leukocytosis (increased white blood cells)
  9. Abdominal discomfort
  10. Activated partial thromboplastin time prolonged

Butazolidin side effects by gender *:

female:

  1. Drug hypersensitivity
  2. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands)
  3. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  4. Abdominal pain
  5. Drug ineffective
  6. Abdominal discomfort
  7. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  8. Allergy to arthropod sting
  9. Anxiety
  10. Asthenia (weakness)

male:

  1. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  2. Lung neoplasm malignant (cancer tumour of lung)
  3. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  4. Calculus ureteric (stone in ureter)
  5. Cat scratch disease (bacterial infection by cat scratch)
  6. Cerebral thrombosis (blood clot in brain)
  7. Crohn's disease (condition that causes inflammation of the gastrointestinal tract)
  8. Diabetes mellitus inadequate control
  9. Disseminated tuberculosis
  10. Erysipelas (bacterial skin infection)

Butazolidin side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cheilitis (infection of lips)
  2. Leukocytosis (increased white blood cells)

30-39:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Deafness bilateral
  3. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  4. Disseminated tuberculosis
  5. Drug ineffective
  6. Oedema peripheral (superficial swelling)

40-49:

  1. Ankylosing spondylitis (type of arthritis affecting the spine)
  2. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  3. Anxiety
  4. Calculus ureteric (stone in ureter)
  5. Drug exposure during pregnancy
  6. Hepatosplenomegaly (enlargement of both the liver and the spleen)
  7. Liposarcoma (a cancer tumour that arises in fat cells in deep soft tissue)
  8. Pulmonary tuberculosis (lungs tuberculosis)

50-59:

  1. Lung neoplasm malignant (cancer tumour of lung)
  2. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands)
  3. Abdominal pain
  4. Activated partial thromboplastin time prolonged
  5. Anaemia (lack of blood)
  6. Crohn's disease (condition that causes inflammation of the gastrointestinal tract)
  7. Diabetes mellitus inadequate control
  8. Hypertension (high blood pressure)

60+:

  1. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  2. Drug hypersensitivity
  3. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  4. Asthenia (weakness)
  5. Erysipelas (bacterial skin infection)
  6. Gingival bleeding (bleeding gums)

* Approximation only. Some reports may have incomplete information.

Do you take Butazolidin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on phenylbutazone (the active ingredients of Butazolidin) and Butazolidin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Butazolidin:

All Butazolidin side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: